R. P. Baughman (Cincinnati, Oh, United States of America), P. Rottoli (Siena, Italy)
Audit of the prescribing practise in IPF following the publication of the ifigenia study
J. Cosgrove, G. Jenkins (Nottingham, United Kingdom)
|   |
Enhanced effects of pirfenidone on the early phase of idiopathic pulmonary fibrosis (IPF)
M. Ebina, Y. Kimura, H. Ohta, S. Ohkouchi, S. Hisata, N. Hirota, T. Tamada, T. Nukiwa, Clinical Study Group of Pirfenidone in Japan (Sendai, Japan)
| |
Disease severity for enrollment criteria of patients with idiopathic pulmonary fibrosis (IPF) in clinical trial: evaluation of time to first episode of acute exacerbation (TTA)
S. Ohkouchi, T. Abe, Y. Taguchi, M. Ebina, T. Nukiwa (Sendai, Tenri, Japan)
| |
Role of leukotriene receptor antagonist on TGF-β1 and Smad signalling in bleomycin induced pulmonary fibrosis
B. G. Lee, W. Y. Lee, S. J. Yong, S. T. Kim, J. Y. Park, S. H. Jung, S. N. Lee, S. H. Kim, K. C. Shin (Wonju, Republic Of Korea)
| |
Idiopathic pulmonary fibrosis and pregnancy: a case controlled study
W. Hassan, A. Darwish (Assiut, Egypt)
| |
Retrospective analysis of acute exacerbation in idiopathic interstitial pneumonias
T. Arai, Y. Inoue, K. Tachibana, Y. Inoue, A. Nishiyama, C. Sugimoto, Y. Sasaki, T. Kagawa, J. Otsuka, Y. Matsuda, M. Akira, M. Kitaichi, S. Hayashi, M. Sakatani (Sakai, Japan)
| |
Collagen formation and nuclear factor-kappa B activation in experimental pulmonary fibrosis in rats
X. Wang, S. Cui, X. Wu, X. Yang (Chongqing, China)
| |
Analysis of pulmonary function in patients with idiopathic pulmonary fibrosis (IPF): how stable is stable IPF?
L. Shulgina, R. Islam, A. Wilson (Norwich, United Kingdom)
| |
Steroid osteoporosis prevention in patients with idiopathic pulmonary fibrosis
A. Ulitina, D. Dzadzua, N. Lubov‘, I. Yulia, M. Dubina (St. Petersburg, Russian Federation)
| |
Pulmonary tuberculosis (TB) as a complication of idiopathic pulmonary fibrosis (IPF)
G. Kaczmarczyk, D. Jastrzebski, D. Ziora, J. Kozielski (Zabrze, Poland)
| |
Long-term efficacy and safety of N-acetylcysteine inhalation in patients with idiopathic pulmonary fibrosis
M. Bando, T. Hosono, H. Yamasawa, Y. Sugiyama (Shimotsuke, Japan)
| |
Impulse oscillometry parameters in patients with idiopathic pulmonary fibrosis (IPF) with different severity grades of restrictive disorders
L. Kiryukhina, L. Novikova, M. Kameneva, N. Yakovleva (Saint-Petersburg, Russian Federation)
| |
The effects of AMD3100, a CXCR4 antagonist, on the bleomycin-induced pulmonary fibrosis
J. S. Song, C. M. Kang, J. Y. Kang, H. K. Yoon, S. H. Park (Seoul, Republic Of Korea)
| |
Angiogenesis in experimental pulmonary fibrosis
X. Wang, S. Cui, X. Wu, X. Yang (Chongqing, China)
| |
Can mycophenolate mofetil 15 mg/kg/day attenuate experimental pulmonary fibrosis in rats?
M. Ben Brahim, S. Maalej, N. Kourda, M. Damek, L. Gharbi, S. Ben Khamsa (Tunis, Tunisia, Tunisia)
| |
Effect of administration of purified fish oil on bleomycin induced lung fibrosis in rats
M. Ben Brahim, N. Kourda, O. Ben Abdelkader, L. Gharbi, F. Tritar, S. Ben Khamsa (Tunisia, Tunisia)
| |
Effect dose response of dietary crude tuna oil in bleomycine induced lung fibrosis in rats
O. Ben Abdelkader, M. Ben Brahim, N. Kourda, F. Tritar, S. Nigrou, S. Ben Khamsa (Tunisia, Tunisia)
| |
Evaluation of health-related quality of life using St George‘s Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: cross-sectional and longitudinal study
E. K. Kim, J. W. Song, J. W. Yoo, D. S. Kim (Seongnam, Seoul, Republic Of Korea)
| |
Is steroid therapy needed in IPF or not?
A. Merzi Ozturk, N. Demir Firat, D. Karnak, O. Kayacan (Ankara, Turkey)
| |